GLP-1s began as prescriptions for conditions like diabetes and sleep apnea. The Persistent argues they have now moved into the beauty industry.
Recap by typeshit. Post by @readthepersistent on Instagram.
The MFDS approval rests on SURPASS-CVOT, where Mounjaro matched Trulicity on heart events in 13,000+ patients but did not prove superior.
Inside Retail Asia looks at skincare and aesthetic treatments brands are building for facial volume loss after rapid weight loss.
The actor told an interviewer people can take Ozempic carefree, while stressing that nothing replaces actually working out.
CFO MV Narasimham says the company still expects to ship 6 to 7 million pens across 10 approved markets between November and March, with Canada taking most of them.
Reporter Maxmen digs into why unproven peptides have caught on with wellness influencers, biohackers and some doctors. The full reporting is linked from KFF's profile.
eMarketer says weight loss drug brands online need clear pricing and ongoing personal care if they want to hold on to patients.
Loading…